AU2001237543A1 - Proteins, genes and their use for diagnosis and treatment of schizophrenia - Google Patents
Proteins, genes and their use for diagnosis and treatment of schizophreniaInfo
- Publication number
- AU2001237543A1 AU2001237543A1 AU2001237543A AU3754301A AU2001237543A1 AU 2001237543 A1 AU2001237543 A1 AU 2001237543A1 AU 2001237543 A AU2001237543 A AU 2001237543A AU 3754301 A AU3754301 A AU 3754301A AU 2001237543 A1 AU2001237543 A1 AU 2001237543A1
- Authority
- AU
- Australia
- Prior art keywords
- schizophrenia
- genes
- diagnosis
- proteins
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/302—Schizophrenia
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0004415 | 2000-02-24 | ||
GB0004415A GB0004415D0 (en) | 2000-02-24 | 2000-02-24 | Proteins and their use for diagnosis and treatment of schizophrenia |
US09750395 | 2000-11-28 | ||
US75039500A | 2000-12-28 | 2000-12-28 | |
PCT/GB2001/000792 WO2001062785A2 (en) | 2000-02-24 | 2001-02-23 | Protein and gene and their use for diagnosis and treatment of schizophrenia |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001237543A1 true AU2001237543A1 (en) | 2001-09-03 |
Family
ID=26243725
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001237543A Abandoned AU2001237543A1 (en) | 2000-02-24 | 2001-02-23 | Proteins, genes and their use for diagnosis and treatment of schizophrenia |
AU2001233954A Abandoned AU2001233954A1 (en) | 2000-02-24 | 2001-02-23 | Proteins, genes and their use for diagnosis and treatment of schizophrenia |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001233954A Abandoned AU2001233954A1 (en) | 2000-02-24 | 2001-02-23 | Proteins, genes and their use for diagnosis and treatment of schizophrenia |
Country Status (3)
Country | Link |
---|---|
EP (2) | EP1259607A2 (en) |
AU (2) | AU2001237543A1 (en) |
WO (2) | WO2001062785A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002083921A2 (en) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
SG121733A1 (en) * | 2001-10-03 | 2006-05-26 | Pfizer Prod Inc | Nucleic acid molecules polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease |
US20030100012A1 (en) * | 2001-11-23 | 2003-05-29 | George Jackowski | Plasma protease C1 biopolymer markers predictive of alzheimers disease |
US7052849B2 (en) * | 2001-11-23 | 2006-05-30 | Syn X Pharma, Inc. | Protein biopolymer markers predictive of insulin resistance |
WO2003072543A2 (en) | 2002-02-21 | 2003-09-04 | Quark Biotech, Inc. | Methods of preventing or treating brain ischemia or brain injury |
CN1300588C (en) * | 2005-02-28 | 2007-02-14 | 上海交通大学 | Method for acquiring plasma specific protein for schizophrenia diagnosis and use thereof |
GB0701626D0 (en) * | 2007-01-22 | 2007-03-07 | Cambridge Entpr Ltd | Methods and biomarkers for diagnosing and monitoring psychotic disorders |
WO2010079511A2 (en) * | 2008-12-27 | 2010-07-15 | Pawan Saharan | Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6319687B1 (en) * | 1992-09-24 | 2001-11-20 | The United States Of America As Represented By The Department Of Health And Human Services | Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene |
US5767252A (en) * | 1996-04-08 | 1998-06-16 | The Johns Hopkins University School Of Medicine | Neuronal cell growth factor, Narp |
WO1998011222A1 (en) * | 1996-09-13 | 1998-03-19 | The Mount Sinai School Of Medicine Of The City University Of New York | Screening methods for compounds useful in the treatment of schizophrenia |
AU6465798A (en) * | 1997-03-14 | 1998-09-29 | Neuromark | Diagnosing neurologic disorders |
US5939316A (en) * | 1997-03-27 | 1999-08-17 | Millennium Pharmaceuticals, Inc. | Chromosome 18 marker |
EP1012300A1 (en) * | 1997-09-05 | 2000-06-28 | Acorda Therapeutics | Hnk-1 sulfotransferase and methods of use therefor |
CA2303834A1 (en) * | 1997-09-17 | 1999-03-25 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US6248527B1 (en) * | 1998-10-21 | 2001-06-19 | Millennium Pharmaceuticals, Inc. | Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E |
AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
WO2001025268A1 (en) * | 1999-10-04 | 2001-04-12 | Schrotz King Petra | Human seizure related proteins |
EP1101820A1 (en) * | 1999-11-15 | 2001-05-23 | MERCK PATENT GmbH | Pentraxin I and Pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
-
2001
- 2001-02-23 WO PCT/GB2001/000792 patent/WO2001062785A2/en not_active Application Discontinuation
- 2001-02-23 EP EP01909957A patent/EP1259607A2/en not_active Withdrawn
- 2001-02-23 EP EP01905991A patent/EP1259818A2/en not_active Withdrawn
- 2001-02-23 WO PCT/GB2001/000783 patent/WO2001063293A2/en not_active Application Discontinuation
- 2001-02-23 AU AU2001237543A patent/AU2001237543A1/en not_active Abandoned
- 2001-02-23 AU AU2001233954A patent/AU2001233954A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001063293A3 (en) | 2002-04-11 |
WO2001063293A8 (en) | 2001-10-18 |
WO2001063293A2 (en) | 2001-08-30 |
EP1259818A2 (en) | 2002-11-27 |
AU2001233954A1 (en) | 2001-09-03 |
WO2001062785A3 (en) | 2002-01-31 |
WO2001062785A2 (en) | 2001-08-30 |
EP1259607A2 (en) | 2002-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002216273A1 (en) | Proteins, genes and their use for diagnosis and treatment of kidney response | |
AU2001288249A1 (en) | Biosensors and methods for their use | |
AU2002251366A1 (en) | Proteins, genes and their use for diagnosis and treatment of breast cancer | |
AU2001240909A1 (en) | Proteins, genes and their use for diagnosis and treatment of breast cancer | |
AU2002258728A1 (en) | Gene brcc-3 and diagnostic and therapeutic uses thereof | |
AU7748200A (en) | Hypoxia-related human genes, proteins, and uses thereof | |
AU6583700A (en) | Proteins, genes and their use for diagnosis and treatment of breast cancer | |
AU2002305151A1 (en) | Gene scc-112 and diagnostic and therapeutic uses thereof | |
AU2002303261A1 (en) | Gene brcc2 and diagnostic and therapeutic uses thereof | |
AU2001233954A1 (en) | Proteins, genes and their use for diagnosis and treatment of schizophrenia | |
AU2067501A (en) | Human oxidoreductase proteins | |
AU2001240820A1 (en) | Proteins, genes and their use for diagnosis and treatment of vascular dementia | |
MXPA02008238A (en) | Human schizophrenia gene. | |
AU2002251367A1 (en) | Proteins and genes for diagnosis and treatment of erbb2-related cancer | |
AU2002222308A1 (en) | Proteins, genes and their use for diagnosis and treatment of vascular response | |
AU5611701A (en) | Agent for the diagnosis and therapy of viral diseases | |
AU2001268053A1 (en) | Human sparc-homologous (hsparc-h1) gene and methods and uses thereof | |
AU2002222169A1 (en) | Proteins, genes and their use for diagnosis and treatment of chronic asthma | |
AU2002222307A1 (en) | Proteins, genes and their use for diagnosis and treatment of cardiac response | |
AU2001292500A1 (en) | 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain | |
GB0004415D0 (en) | Proteins and their use for diagnosis and treatment of schizophrenia | |
AU2002225852A1 (en) | "67118", "67067" and "62092", human proteins and methods of use thereof | |
AU2002245158A1 (en) | Human proteins 55562 and 21617, and methods of use thereof | |
AU2002217110A1 (en) | Fractions of snake blood, their preparation and use as therapeutic agents | |
AU7304000A (en) | Virulence gene and protein, and their use |